ArticleAmerican journal of hematology2018

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.

Jessica K Altman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.